AJANTPHARM2022-01-012022-03-31in-bse-fin:OneOperatingExpenses01Member AJANTPHARM2022-01-012022-03-31in-bse-fin:FourOperatingExpenses01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares AJANTPHARM 2021-04-01 2022-03-31 2022-05-02 INR Crores Yearly true Cash Flow Indirect Single segment PHARMACEUTICAL 2022-01-01 2022-03-31 Audited Standalone 7656300000.00 284200000.00 7940500000.00 2170100000.00 291300000.00 -452700000.00 1461100000.00 71800000.00 300900000.00 2315000000.00 6157500000.00 1783000000.00 0.00 1783000000.00 469500000.00 -34900000.00 434600000.00 0.00 1348400000.00 0.00 0.00 0.00 0.00 1348400000.00 13200000.00 1361600000.00 1361600000.00 0.00 171700000.00 2 15.79 15.79 0.00 0.00 15.79 15.79 Notes : 1. The above standalone results have been reviewed by Audit Committee and approved by the Board of Directors at their meeting held on 10 May 2022. The statutory auditors have expressed an unmodified opinion on the results for the quarter and year ended 31 March 2022. The review report has been filed with the stock exchange and is available on the company's website. 2. The figures for the quarter ended 31 March 2022 and 31 March 2021 are the balancing figures between audited figures in respect of full financial year and the unaudited published year to date figures upto the third quarter ended 31 December 2021 and 31 December 2020 respectively. 3. Other income includes : Dividend from subsidiaries (Rs. in Crore) Quarter ended Year ended 31-Mar-22 31-Dec-21 31-Mar-21 31-Mar-22 31-Mar-21 ---- ---- ---- 22.33 83.21 4. During the year 4,000 (previous year 5,500) equity shares of Rs. 2 each, fully paid up, were allotted upon exercise of vested options pursuant to the Employees Stock Options Scheme, 2011, resulting in an increase in the paid-up share capital by Rs. 8,000 (previous year Rs. 11,000) and securities premium by Rs. 0.54 crores (previous year Rs. 0.58 crores). 5. During the year, Company had bought back its 11,20,000 equity shares (previous year 7,35,000 equity shares), being 1.29% (previous year 0.84%) of the total paid up equity share capital at Rs. 2,550 (previous year Rs. 1,850) per equity share for an aggregate amount of Rs. 285.60 crores (previous year Rs. 135.98 crores) and extinguished those shares on 28 February 2022. 6. Board of Directors have approved Bonus Shares in the ratio of One Equity Share of Rs. 2 each for every Two Equity Share of Rs. 2 each held by the shareholders on the record date, subject to approval of shareholders. 7. The Company continued to take into account the possible impacts of COVID-19 in preparation of the financial statements, including but not limited to its assessment of liquidity and going concern assumption, recoverable values of its financial and non-financial assets, impact on revenues and on costs. The Company has been able to effectively manage the operations till now with appropriate safety precautions, without any significant impact of COVID-19 on the business. The Company will continue to closely monitor future economic conditions to ensure business continuity. 8. The Company operates exclusively in one reportable business segment i.e., Pharmaceuticals . 9. The Financial Results are available on the company's website www.ajantapharma.com, www.nseindia.com and www.bseindia.com. 10. Previous period figures have been re-grouped / re-classified wherever necessary, to confirm to current period’s classification in order to comply with the requirements of the amended Schedule III to the Companies Act, 2013 effective 01 April 2021. Single segment 2021-04-01 2022-03-31 Audited Standalone 31406400000.00 1397300000.00 32803700000.00 7730400000.00 1161200000.00 -566000000.00 5858700000.00 91200000.00 1209600000.00 8313200000.00 23798300000.00 9005400000.00 0.00 9005400000.00 1711700000.00 95100000.00 1806800000.00 0.00 7198600000.00 0.00 0.00 0.00 0.00 7198600000.00 3600000.00 7202200000.00 7202200000.00 0.00 171700000.00 2 0.00 83.28 83.28 0.00 0.00 83.28 83.28 Other Expenses 2315000000.00 Other Expenses 8313200000.00 91200000.00 -8900000.00 -2441700000.00 0.00 297700000.00 100000.00 43100000.00 48700000.00 0.00 -434300000.00 0.00 238600000.00 3400000.00 1209600000.00 75600000.00 -5400000.00 13900000.00 40000000.00 -1600000.00 -211900000.00 223300000.00 123500000.00 3000000.00 -261600000.00 0.00 0.00 0.00 0.00 0.00 -1647300000.00 7358100000.00 0.00 0.00 0.00 1934700000.00 200000.00 5423600000.00 0.00 0.00 10640400000.00 10378700000.00 0.00 0.00 0.00 250000000.00 183900000.00 1465300000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 223300000.00 119200000.00 0.00 266800000.00 0.00 -660400000.00 0.00 0.00 0.00 0.00 3541200000.00 0.00 0.00 0.00 0.00 0.00 0.00 144700000.00 822100000.00 65200000.00 0.00 0.00 -4573200000.00 190000000.00 9500000.00 199500000.00 1198800000.00 1398300000.00